ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1920

Spectrum of IgG4-Related Disease and Diagnostic Value of Serum IgG4 Determinations

Emma Kotisalmi1, Tom Pettersson2, Aaro Miettinen3, Johanna Arola4 and Martti Färkkilä5, 1Department of Medicine, University of Helsinki, Helsinki, Finland, 2Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland, 3Department of Immunology, Huslab, Helsinki, Finland, 4Department of Pathology, University of Helsinki and Huslab, Helsinki, Finland, 5Department of Gastroenterology, Helsinki University Central Hospital, Helsinki, Finland

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Immunoglobulin (IG)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: IgG4-related disease is a recently described systemic inflammatory and fibrosing condition that may mimic various other systemic rheumatic diseases. We studied the occurrence of IgG4-related disease over a one year period at a university hospital serving a population of 1.5 million, and assessed the diagnostic significance of a serum IgG4 concentration higher than the upper level of the reference interval.

Methods: Files were scrutinized for a diagnosis of IgG4-related disease over a one year period (May 2010 to May 2011). The diagnosis rested on the combination of a clinical picture consistent with IgG4-related disease and histopathological features showing a characteristic appearance with a dense lymphoplasmacytic infiltration, a pattern of fibrosis, and variable numbers of IgG4 positive plasma cells. In addition, the files of all patients with a serum IgG4 concentration higher than 1.40 g/l, determined for various reasons during the same time period, were examined and the diagnoses were recorded. IgG subclasses in serum were analysed with a BN II nephelometer using N AS IgG1, N AS IgG2, N Latex IgG3, and N Latex IgG4 reagents (Siemens, Marburg, Germany). The reference interval for IgG4 at our laboratory is 0.08–1.4 g/l.

Results: 14 patients (12 men and 2 women, mean age 61 years, range 40–78 years) were diagnosed with IgG4-related disease during the one-year study period. In 3 patients the disease was confined to a single organ, whereas the other 11 had multiorgan involvement. The presenting features and major manifestations were autoimmune pancreatitis in 10, autoimmune cholangitis in 10, Mikulicz disease in 3, Riedel’s thyroiditis in 2, retroperitoneal fibrosis in 1, and mediastinal fibrosis in 1. Three had a diagnosis of bronchial asthma. Median serum IgG4 concentration at diagnosis was 7.75 g/l with a range of 1.66–18.20 g/l. No patients with a diagnosis of IgG4-related disease and normal serum IgG4 concentrations were identified. Major diagnoses suspected at referral included pancreatic carcinoma, liver disease, primary Sjögren’s syndrome, sarcoidosis, lymphoma, and vasculitis. Over the same time period no less than 238 additional patients with a serum IgG4 concentration higher than 1.40 g/l (median 2.22 g/l, range 1.41–11.50 g/l) were recorded. The most common diagnoses among these patients were bronchial asthma, chronic sinusitis and various allergic conditions, but high values were observed in a wide range of other diseases including sclerosing cholangitis, inflammatory bowel disease, and vasculitis.

Conclusion: We confirmed previous observations that IgG4-related disease occurs predominantly in middle aged or elderly men. Awareness of this newly recognized condition is essential since it constitutes a major differential diagnosis against various systemic inflammatory diseases and other diseases including lymphoma and other neoplasia. In our series a high serum IgG4 concentration was a regular finding among patients with IgG4-related disease. However, serum IgG4 concentrations higher than normal also occurred in a great variety of other diseases.


Disclosure:

E. Kotisalmi,
None;

T. Pettersson,
None;

A. Miettinen,
None;

J. Arola,
None;

M. Färkkilä,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/spectrum-of-igg4-related-disease-and-diagnostic-value-of-serum-igg4-determinations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology